Skip to content

A randomised controlled trial comparing the Gonadotrophin Releasing Hormone agonist long regimen versus the Gonadotrophin Releasing Hormone agonist short regimen versus the Gonadotrophin Releasing Hormone antagonist regimen in poor responders undergoing in vitro fertilisation treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN27044628
Enrollment
102
Registered
2006-10-27
Start date
2006-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor ovarian response in In Vitro Fertilisation (IVF) Pregnancy and Childbirth Poor ovarian response in In Vitro Fertilisation (IVF)

Interventions

Each intervention group will be receiving one of the following treatments: 1. The Gonadotrophin Releasing Hormone (GnRH) agonist long regimen 2. The GnRH agonist short regimen 3. The GnRH antagonist r

Sponsors

Guy's and St Thomas' NHS Foundation Trust and King' s College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Any woman undergoing an IVF treatment cycle with or without Intra Cytoplasmic Sperm Injection (ICSI) who is considered to be a "poor responder" is eligible to participate in the trial. For this study a "poor responder" is defined as a woman who had a previous IVF treatment cycle in which she was stimulated with a daily dose of Follicle Stimulating Hormone (FSH) of 300 IU or more for at least nine days and: 1. Produced an inadequate number of mature follicles (three or less follicles measuring more than or equal to 17 mm, or 2. Had three or less oocytes retrieved at oocyte retrieval

Exclusion criteria

Exclusion criteria: 1. Women aged more than 40 years 2. Women with a single ovary

Design outcomes

Primary

MeasureTime frame
Number of oocytes retrieved at egg collection

Secondary

MeasureTime frame
1. Total FSH dose used for ovarian stimulation 2. Number of mature oocytes retrieved 3. Number of embryos available for transfer 4. Clinical pregnancies (ultrasound evidence of foetal heart at eight weeks gestation)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 6, 2026